Stock EUCR EUCRATES BIOMEDICAL ACQUISITION CORP.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Eucrates Biomedical Acquisition Corp.

Equities

EUCR

VGG3141W1068

Investment Holding Companies

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration

Latest news about Eucrates Biomedical Acquisition Corp.

Eucrates Biomedical Acquisition Corp.(NasdaqCM:EUCR) dropped from NASDAQ Composite Index CI
Eucrates Biomedical Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Eucrates Biomedical Acquisition Corp. Auditor Raises 'Going Concern' Doubt CI
Eucrates Biomedical Acquisition to Dissolve, Liquidate MT
Eucrates Biomedical Acquisition Corp. announced that it has received $0.096 million in funding from Eucrates Llc CI
Eucrates Biomedical Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Eucrates Biomedical Acquisition Corp. announced that it has received $0.6 million in funding from Eucrates Llc CI
Eucrates Biomedical Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Eucrates Biomedical Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Eucrates Biomedical Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Eucrates Biomedical Acquisition Corp. Auditor Raises 'Going Concern' Doubt CI
Eucrates Biomedical Acquisition Corp. announced that it expects to receive $0.6 million in funding from Eucrates Llc CI
Eucrates Biomedical Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Eucrates Biomedical Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Eucrates Biomedical Acquisition : Receives Non-Compliance Notice from Nasdaq MT
Certain Ordinary Shares of Eucrates Biomedical Acquisition Corp. are subject to a Lock-Up Agreement Ending on 22-APR-2021. CI
Eucrates Biomedical Acquisition Corp. Announces Earnings Results for the Period from August 21, 2020 to December 31, 2020 CI
Eucrates Biomedical Acquisition Corp.(NasdaqCM:EUCR) added to NASDAQ Composite Index CI
Eucrates Biomedical Acquisition Corp. announced that it has received $3.5 million in funding from Eucrates Llc CI
Eucrates Biomedical Acquisition Corp. has completed an IPO in the amount of $100 million. CI
Eucrates Biomedical Acquisition Corp. has filed an IPO in the amount of $100 million. CI
Eucrates Biomedical Acquisition Corp. announced that it expects to receive $3.5 million in funding from Eucrates Llc CI

Chart Eucrates Biomedical Acquisition Corp.

Chart Eucrates Biomedical Acquisition Corp.
More charts

Company Profile

Eucrates Biomedical Acquisition Corp. is a blank check company. The Company is formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation with, purchasing all or substantially all of the assets of, entering into contractual arrangements with, or engaging in any other similar business combination with one or more businesses or entities. The Company intends to focus on businesses focusing on the biomedical or healthcare-related industries. The Company is not engaged in any business operations and has generated any revenue.
Sector
Investment Holding Companies
More about the company

Sector Shell Companies

1st Jan change Capi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP. Stock Trump Media & Technology Group Corp.
+137.37% 5.68B
SCREAMING EAGLE ACQUISITION CORP. Stock Screaming Eagle Acquisition Corp.
+1.89% 1.01B
CHURCHILL CAPITAL CORP VII Stock Churchill Capital Corp VII
+2.19% 982M
APPLE ISPORTS GROUP, INC. Stock Apple iSports Group, Inc.
+41.91% 872M
PERELLA WEINBERG PARTNERS Stock Perella Weinberg Partners
+25.27% 819M
ARES ACQUISITION CORPORATION II Stock Ares Acquisition Corporation II
+1.68% 663M
E7 GROUP Stock E7 Group
+0.54% 610M
DA ZHONG TRADING GROUP HOLDING COMPANY Stock Da Zhong Trading Group Holding Company
-.--% 600M
ALTC ACQUISITION CORP. Stock AltC Acquisition Corp.
+21.31% 552M
Shell Companies
  1. Stock Market
  2. Equities
  3. EUCR Stock
  4. News Eucrates Biomedical Acquisition Corp.
  5. Eucrates Biomedical Acquisition to Dissolve, Liquidate